Related references
Note: Only part of the references are listed.Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer Results From an International Collaboration
M. E. Kelly et al.
ANNALS OF SURGERY (2019)
Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer
M. E. Kelly et al.
BRITISH JOURNAL OF SURGERY (2018)
Tumor Regression Grade After Neoadjuvant Chemoradiation and Surgery for Low Rectal Cancer Evaluated by Multiple Correspondence Analysis: Ten Years as Minimum Follow-up
Raffaello Mancini et al.
CLINICAL COLORECTAL CANCER (2018)
Management and prognosis of locally recurrent rectal cancer - A national population-based study
Karin Westberg et al.
EJSO (2018)
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Andrea Cercek et al.
JAMA ONCOLOGY (2018)
Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study
Xin Yu et al.
CANCER COMMUNICATIONS (2018)
Preliminary results of a cohort study of induction chemotherapy-based treatment for locally recurrent rectal cancer
D. M. G. I. van Zoggel et al.
BRITISH JOURNAL OF SURGERY (2018)
Population-based study of factors predicting treatment intention in patients with locally recurrent rectal cancer
K. Westberg et al.
BRITISH JOURNAL OF SURGERY (2017)
Complete Neoadjuvant Treatment for Rectal Cancer: The Brown University Oncology Group CONTRE Study
Kimberly Perez et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2017)
Local Recurrence in the Lateral Lymph Node Compartment: Improved Outcomes with Induction Chemotherapy Combined with Multimodality Treatment
Miranda Kusters et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Treatment of Locally Recurrent Rectal Carcinoma in Previously (Chemo)Irradiated Patients: A Review
Wout van der Meij et al.
DISEASES OF THE COLON & RECTUM (2016)
Early and Late Outcomes of Surgery for Locally Recurrent Rectal Cancer: A Prospective 10-Year Study in the Total Mesorectal Excision Era
Mette Nielsen et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
The Importance of a Minimal Tumor-Free Resection Margin in Locally Recurrent Rectal Cancer
Wijnand J. Alberda et al.
DISEASES OF THE COLON & RECTUM (2015)
American Joint Committee on Cancer and College of American Pathologists Regression Grade: A New Prognostic Factor in Rectal Cancer
Adam G. Mace et al.
DISEASES OF THE COLON & RECTUM (2015)
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial
Julio Garcia-Aguilar et al.
LANCET ONCOLOGY (2015)
Tumor regression grades: Potential outcome predictor of locally advanced rectal adenocarcinoma after preoperative radiotherapy
Yi-Fan Peng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Feasibility of reirradiation in the treatment of locally recurrent rectal cancer
S. J. Bosman et al.
BRITISH JOURNAL OF SURGERY (2014)
Neoadjuvant Chemotherapy First, Followed by Chemoradiation and Then Surgery, in the Management of Locally Advanced Rectal Cancer
Andrea Cercek et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)
Chemoradiotherapy response in recurrent rectal cancer
Stanley K. T. Yu et al.
CANCER MEDICINE (2014)
Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes
A. Bhangu et al.
BRITISH JOURNAL OF SURGERY (2013)
Intentionally curative treatment of locally recurrent rectal cancer: a systematic review
Pieter J. Tanis et al.
CANADIAN JOURNAL OF SURGERY (2013)
Current management of locally recurrent rectal cancer
M. B. Nielsen et al.
COLORECTAL DISEASE (2011)
Phase II, Randomized Study of Concomitant Chemoradiotherapy Followed by Surgery and Adjuvant Capecitabine Plus Oxaliplatin (CAPOX) Compared With Induction CAPOX Followed by Concomitant Chemoradiotherapy and Surgery in Magnetic Resonance Imaging-Defined, Locally Advanced Rectal Cancer: Grupo Cancer de Recto 3 Study
Carlos Fernandez-Martos et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial
Yu Jo Chua et al.
LANCET ONCOLOGY (2010)
RADICALITY OF RESECTION AND SURVIVAL AFTER MULTIMODALITY TREATMENT IS INFLUENCED BY SUBSITE OF LOCALLY RECURRENT RECTAL CANCER
Miranda Kusters et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer
Raphaela C. Dresen et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study
V Valentini et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer
I Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer
C Rödel et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Clinical outcome in patients with complete pathologic response (pT0) to preoperative irradiation/chemo-irradiation operated for locally advanced or locally recurrent rectal cancer
JN Wiig et al.
JOURNAL OF SURGICAL ONCOLOGY (2005)
The relationship of pathologic tumor regression grade (TGR) and outcomes after preoperative therapy in rectal cancer
FM Vecchio et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Preoperative radiotherapy improves outcome in recurrent rectal cancer
M Vermaas et al.
DISEASES OF THE COLON & RECTUM (2005)
Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
D Dindo et al.
ANNALS OF SURGERY (2004)
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
E Kapiteijn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)